True Integral NEB002
True Integral NEB002 is a therapeutic agent nebulizer (FDA Class II; FDA product code CAF, Nebulizer (Direct Patient Interface)) made by True Integral Inc, cleared under FDA 510(k) K171549 on 31 Aug 2018 and listed in FDA GUDID since 27 Dec 2019 (UDI-DI 00860003079706), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00860003079706 | Date27 Dec 2019 | StatusListed |
| United States | FDA 510(k)SESE | NumberK171549 | Date31 Aug 2018 | StatusActive |
Official records
- AccessGUDID record 00860003079706
- FDA 510(k) database K171549
Across registries
- FDA 510(k) K171549 decided 31 Aug 2018 Active
- FDA GUDID UDI-DI 00860003079706 listed 27 Dec 2019 Listed
Timeline
- Cleared FDA 510(k) K171549
- Listed FDA GUDID 00860003079706
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- True Integral
- Generic name
- Therapeutic agent nebulizer, benchtop
- Model / reference
- NEB002
- Primary DI / UDI-DI
- 00860003079706
- FDA product code
- CAF
- GMDN term
- Therapeutic agent nebulizer, benchtop
- Device class
- Class II
- Regulation number
- 868.5630
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Therapeutic agent nebulizer, benchtop.